Search - tctmd.com

Displaying 301 - 320 of 972

Sort: Relevancy | Date

News Daily News

UK’s NICE Recommends Lower-Risk Thresholds for Statin Therapy

Michael O'Riordan

January 20, 2023

News Daily News

PCSK9 Inhibition Shows Promise for Severe COVID-19 in Pilot Trial

Todd Neale

January 18, 2023

News Daily News

Zero CAC? LDL Cholesterol May Not Predict MI, ASCVD

Yael L. Maxwell

January 17, 2023

News Daily News

Sustained LDL-Cholesterol Reductions With Inclisiran: ORION-3

Michael O'Riordan

January 16, 2023

News Daily News

Meeting WHO’s Sodium Benchmarks Would Cut Deaths, Illness, Model Suggests

L.A. McKeown

January 10, 2023

News Opinion Editor's Corner

The Biggest News of 2022: TCTMD’s Top 10

Shelley Wood

December 30, 2022

News Daily News

CVD Benefits of Activity Seen Below Widely Quoted Step Goal in Older Adults

Michael O'Riordan

December 28, 2022

News Daily News

‘Digital Biomarker,’ Derived From EHR, Can Diagnose and Describe CAD

Yael L. Maxwell

December 27, 2022

News Daily News

Effect of Intensive BP-Lowering on Cardiac Biomarkers Varies: SPRINT Analysis

Todd Neale

December 23, 2022

News Daily News

Reduction in BP Drives Treatment Preference for Hypertensive Patients

Michael O'Riordan

December 20, 2022

News Daily News

Global Cardio-Oncology Viewpoints ‘Contextualize’ ESC Guidelines

L.A. McKeown

December 12, 2022

News Daily News

Expert Consensus Advocates for Normalizing Pregnancy in Cath Labs

L.A. McKeown

December 08, 2022

News Daily News

A Simple Nudge Moves the Needle on Statin Prescribing

Michael O'Riordan

December 02, 2022

News Daily News

Age-Related Macular Degeneration Linked to Severe Vascular Disease

Caitlin E. Cox

November 18, 2022

News Daily News

How Lp(a) Levels Compare With LDL-C in FH: Some Surprises

Michael O'Riordan

November 17, 2022

News Daily News

Novel Aldosterone Synthase Inhibitor Drops BP: Top-line Phase II Results

Todd Neale

November 16, 2022

News Daily News

Many STEMI Patients Not Treated Within National Time Goals

Michael O'Riordan

November 15, 2022

News Conference News AHA 2022

Sizeable Minority of Pregnant Women Have CVD, US Data Show

Caitlin E. Cox

November 11, 2022

News Conference News AHA 2022

Endothelin Receptor Antagonist Effective in Resistant Hypertension: PRECISION

Michael O'Riordan

November 09, 2022

Advertisement

UK’s NICE Recommends Lower-Risk Thresholds for Statin Therapy

PCSK9 Inhibition Shows Promise for Severe COVID-19 in Pilot Trial

Zero CAC? LDL Cholesterol May Not Predict MI, ASCVD

Sustained LDL-Cholesterol Reductions With Inclisiran: ORION-3

Meeting WHO’s Sodium Benchmarks Would Cut Deaths, Illness, Model Suggests

The Biggest News of 2022: TCTMD’s Top 10

CVD Benefits of Activity Seen Below Widely Quoted Step Goal in Older Adults

‘Digital Biomarker,’ Derived From EHR, Can Diagnose and Describe CAD

Effect of Intensive BP-Lowering on Cardiac Biomarkers Varies: SPRINT Analysis

Reduction in BP Drives Treatment Preference for Hypertensive Patients

Global Cardio-Oncology Viewpoints ‘Contextualize’ ESC Guidelines

Expert Consensus Advocates for Normalizing Pregnancy in Cath Labs

A Simple Nudge Moves the Needle on Statin Prescribing

Age-Related Macular Degeneration Linked to Severe Vascular Disease

How Lp(a) Levels Compare With LDL-C in FH: Some Surprises

Novel Aldosterone Synthase Inhibitor Drops BP: Top-line Phase II Results

Many STEMI Patients Not Treated Within National Time Goals

Sizeable Minority of Pregnant Women Have CVD, US Data Show

Endothelin Receptor Antagonist Effective in Resistant Hypertension: PRECISION

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content